FR941013-1-00043 FR941013-1-00005 (c) No exemption granted pursuant to §1310.14 affects the criminal liability for illegal possession or distribution of listed chemicals contained in the exempt drug product. (d) Changes in drug product compositions: Any change in the quantitative or qualitative composition of an exempt drug product listed in paragraph (e) of this section requires a new application for exemption. (e) In addition to the drug products listed in the compendium set forth in §1310.01(f)(1)(iv)(A), the following drug products, in the form and quantity listed in the application submitted (indicated as the ``date'') are designated as exempt drug products for the purposes set forth in this section: Exempt Drug Products Containing Ephedrine and Therapeutically Significant Quantities of Another Active Medicinal Ingredient 1Supplier 1Product name 1Form 1Date [Reserved] IV. 21 CFR Part 1313 is proposed to be amended as follows: PART 1313_[AMENDED] 1. The authority citation for part 1313 continues to read as follows: Authority: 21 U.S.C. 802, 830, 871(b), 971. 2. Section 1313.02 is proposed to be amended by revising paragraphs (c), (d), (h) and (i); redesignating paragraph (m) as paragraph (o) and adding new paragraphs (m) and (n) to read as follows: §1313.02 Definitions. * * * * * (c) The term regulated person means any individual, corporation, partnership, association, or other legal entity who manufactures, distributes, imports, or exports a listed chemical, a tableting machine, or an encapsulating machine, or who acts as a broker or trader for an international transaction involving a listed chemical, a tableting machine, or an encapsulating machine. (d) The term regulated transaction means: (1) A distribution, receipt, sale, importation, exportation, or international transaction of a listed chemical, or if the Administrator establishes a threshold amount for a specific listed chemical, a threshold amount as determined by the Administrator, which includes a cumulative threshold amount for multiple transactions, of a listed chemical, except that such term does not include: (i) A domestic lawful distribution in the usual course of business between agents or employees of a single regulated person; in this context, agents or employees means individuals under the direct management and control of the regulated person; (ii) A delivery of a listed chemical to or by a common or contract carrier for carriage in the lawful and usual course of the business of the common or contract carrier, or to or by a warehouseman for storage in the lawful and usual course of the business of the warehouseman, except that if the carriage or storage is in connection with the distribution, importation, or exportation of a listed chemical to a third person, this paragraph does not relieve a distributor, importer, or exporter from compliance with this part or parts 1309 and 1310 of this chapter; (iii) Any category of transaction or any category of transaction for a specific listed chemical or chemicals specified by regulation of the Administrator as excluded from this definition as unnecessary for enforcement of the Act; (iv) Any transaction in a listed chemical that is contained in a drug that may be marketed or distributed lawfully in the United States under the Federal Food, Drug, and Cosmetic Act unless_ (A) The drug contains ephedrine or its salts, optical isomers, or salts of optical isomers as the only active medicinal ingredient or contains ephedrine or its salts, optical isomers or salts of optical isomers and therapeutically insignificant quantities of another active medicinal ingredient (for purposes of this paragraph, the term ``therapeutically insignificant quantities'' shall apply if the product formulation (i.e., the qualitative and quantitative composition of active ingredients within the product) is not listed in any of the following compendiums: ( 1 ) American Pharmaceutical Association (APhA) Handbook of Nonprescription Drugs; (2 ) Drug Facts and Comparisons (published by Wolters Kluwer Company); or ( 3 ) USP DI (published by authority of the United States Pharmacopeial Convention, Inc.); ( 4 ) Or the product is not listed in §1310.15 as an exempt drug product. For drug products having formulations not found in the above compendiums, the Administrator shall determine, pursuant to a written request as specified in §1310.14, whether the active medicinal ingredients are present in quantities considered therapeutically significant for purposes of this paragraph. (B) The Administrator has determined that the drug or group of drugs is being diverted to obtain the listed chemical for use in the illicit production of a controlled substance; and
